Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Once in a Blue Moon Short/Put Set Up

echnical analyst Clive Maund charted the S&P 500 and saw a "perfect shorting set-up." Note: This article was originally published on July 31 before the Fed's rate announcement. The charts we will look at in this update suggest that this is a perfect shor...

Aphria, Canopy Growth, EXMceuticals - Europe becomes the largest cannabis market

The consulting firm Prohibition Partners expects Europe to grow into the world's largest market for legal cannabis products in the next five years. Germany will become by far the largest market for medical cannabis products. According to the experts, Europe will thus overtake ...

Buzz on the Bullboards: 3 standout stocks in 3 standout sectors

We are already halfway through July and despite being in the midst of these sleepy summer days, both the business world and Bullboards have certainly picked up in activity. We track the most-viewed Bullboards in each sector every week and bring you some of...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

The Great Dichotomy

One of the advantages of being a sexagenarian is that after forty years investing in stocks, bonds, commodities, and currencies you have a pretty good idea when something is not exactly "right." If you have lived a good, normal life and you still have decent control of ov...

Review of Massively Successful Tech Puts Trades, and Why the Market Has Probably Hit a Bottom Here

Technical analyst Clive Maund discusses trading activity that took advantage of the market's drop. This article was conceived as a "souvenir article" to assist subscribers who did the trade—and I know from feedback that a significant number of you did—in glo...

Central Bank Hypnosis

One look at the chart of the U.S. financial markets against the backdrop of economic paralysis and suffering, and one is immediately filled with a myriad of emotions. Sympathy for those that have been afflicted by the most recent pandemic; fear for the families whose prim...

Rigged Market Socialism

As a child, I used to get quite excited at the prospect of having my English "Gran" read me the Hans Christian Andersen book "The Emperor's New Clothes." I found the tale fiendishly amusing, as the charlatan tailor uses lethal doses of flattery and mystery to beguile t...

A Sound Investment Strategy into Great Vancouver's Booming Real Estate and Student Housing Market

CIBT Education Group Inc. (MBA) ( TSX.MBA , OTCQX: MBAIF , Forum ) is one of the largest education and student housing investment companies in Canada focused on the domestic and the global education market since 1994. The company owns Global Education City Holdings, whi...

Gold Above $1,600 As Iran Retaliates

We didn’t have to wait long for Iran’s response. After the missile attack on U.S. bases in Iraq, gold briefly soared above $1,600. What should we expect next? Iran Retaliates, Gold Rallies On Tuesday, I wrote that “given that Soleimani wa...
1 2 3 4 5 6